Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lachowicz, A.
Right arrow Articles by Stojilkovic, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lachowicz, A.
Right arrow Articles by Stojilkovic, S. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 45, Issue of November 7, 1997 pp. 28308-28314

Uncoupling of Calcium Mobilization and Entry Pathways in Endothelin-stimulated Pituitary Lactotrophs*

(Received for publication, August 6, 1997, and in revised form, September 9, 1997)

Agnieszka Lachowicz , Fredrick Van Goor , Ann C. Katzur , Gabrielle Bonhomme and Stanko S. Stojilkovic Dagger

From the Endocrinology and Reproduction Research Branch, NICHD, National Institutes of Health, Bethesda, Maryland 20892

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

In cells expressing Ca2+-mobilizing receptors, InsP3-induced Ca2+ release from intracellular stores is commonly associated with extracellular Ca2+ influx. Operation of these two Ca2+ signaling pathways mediates thyrotropin-releasing hormone (TRH) and angiotensin II (AII)-induced prolactin secretion from rat pituitary lactotrophs. After an initial hyperpolarization induced by Ca2+ mobilization from the endoplasmic reticulum (ER), these agonists generated an increase in the steady-state firing of action potentials, further facilitating extracellular Ca2+ influx and prolactin release. Like TRH and AII, endothelin-1 (ET-1) also induced a rapid release of Ca2+ from the ER and a concomitant spike prolactin secretion during the first 3-5 min of stimulation. However, unlike TRH and AII actions, Ca2+ mobilization was not coupled to Ca2+ influx during sustained ET-1 stimulation, as ET-1 induced a long-lasting abolition of action potential firing. This lead to a depletion of the ER Ca2+ pool, a prolonged decrease in [Ca2+]i, and sustained inhibition of prolactin release. ET-1-induced inhibition and TRH/AII-induced stimulation of Ca2+ influx and hormone secretion were reduced in the presence of the L-type Ca2+ channel blocker, nifedipine. Basal [Ca2+]i and prolactin release were also reduced in the presence of nifedipine. Furthermore, TRH-induced Ca2+ influx and secretion were abolished by ET-1, as TRH was unable to reactivate Ca2+ influx and prolactin release in ET-1-stimulated cells. Depolarization of the cells during sustained inhibitory action of ET-1, however, increased [Ca2+]i and prolactin release. These results indicate that L-type Ca2+ channel represents a common Ca2+ influx pathway that controls basal [Ca2+]i and secretion and is regulated by TRH/AII and ET-1 in an opposite manner. Thus, the receptor-mediated uncoupling of Ca2+ entry from Ca2+ mobilization provides an effective control mechanism in terminating the stimulatory action of ET-1. Moreover, it makes electrically active lactotrophs quiescent and unresponsive to other calcium-mobilizing agonists.


INTRODUCTION

Typically, in anterior pituitary cells operated by calcium-mobilizing agonists, release of Ca2+ from intracellular Ca2+ stores is associated with extracellular Ca2+ influx. The coordinate actions of these two pathways provide long-lasting Ca2+ signals and secretion during sustained agonist stimulation (1). Endothelins (ETs)1 are common calcium-mobilizing agonists for secretory pituitary cells and operate through ETA receptors (2, 3) coupled to phospholipase C- (4) but not phospholipase D-dependent signaling pathways (5). In lactotrophs, the ET-1-induced release of Ca2+ from intracellular pools is associated with a rapid and transient increase in prolactin secretion (6, 7) followed by a prolonged inhibition to below basal levels (8). This bidirectional effect of a calcium-mobilizing agonist on secretion is uncommon among cells expressing phospholipase C-coupled receptors and is unique for cells expressing ETA receptors. The mechanism underlying the paradoxical action of ETs on hormone secretion is still unknown. It is unlikely that a rapid desensitization of ETA receptors could explain the inhibition of secretion observed in lactotrophs. Therefore, as the sustained phase in hormone secretion is affected in ET-1-stimulated lactotrophs, we addressed the alternate hypothesis that Ca2+ influx is uncoupled from Ca2+ mobilization in ET-1-stimulated lactotrophs, leading to depletion of the ER calcium pool and inhibition of hormone secretion.

To test this hypothesis, rat pituitary lactotrophs were employed. These cells exhibit spontaneous, extracellular Ca2+-dependent action potential (AP) activity (9), which is tightly coupled to basal prolactin secretion (10). In addition to ETA receptors, lactotrophs express thyrotropin-releasing hormone (TRH) receptors (11), the calcium-mobilizing actions of which have been well characterized (12). Angiotensin II (AII) also stimulates prolactin release, presumably through activation of AT1B receptors (13). Two calcium entry pathways are proposed to operate in lactotrophs: voltage-gated (VGCC) and store-operated (SOCC) calcium channels (12). Our results indicate that Ca2+ influx through VGCC rather than through SOCC is essential for the sustained secretagogue actions of TRH and AII. In contrast to these agonists, ET-1 inhibits voltage-gated Ca2+ influx, leading to a depletion of the ER calcium pool, a decrease in [Ca2+]i, and prolonged inhibition of prolactin release.


MATERIALS AND METHODS

Chemicals

GnRH, TRH, AII, and ET-1 were obtained from Peninsula Laboratories (Belmont, CA). Fura 2-AM was purchased from Molecular Probes (Eugene, OR). All other chemicals were purchased from Sigma.

Cell Culture and Hormone Secretion

Anterior pituitary glands from adult female Sprague-Dawley rats obtained from Charles River Inc. (Wilmington, MA) were dispersed into single cells by a trypsin/DNase treatment procedure (14). All experiments were performed in either mixed pituitary cell populations or purified lactotroph populations. Cell purification of dispersed pituitary cells was done by sedimentation on a ficol gradient as described previously (15). For cell column perifusion, 2 × 107 cells were incubated with preswollen cytodex-1 beads in 60-mm culture dishes for 2 days. The cells were then loaded into temperature-controlled chambers and perifused at 37 °C with Hanks' M199 containing 20 mM HEPES and 0.1% bovine serum albumin for 60 min at a flow rate of 0.6 or 1.0 ml/min, after which a stable basal secretion rate was established. During the test period, 3-s or 1-min fractions were collected, and the perifusate was subsequently stored at -20 °C. Prolactin content in each fraction was determined by radioimmunoassay using the reagents and standards provided by the National Pituitary Agency (Baltimore).

Calcium Measurements

Cells were plated on coverslips coated with poly-L-lysine and cultured in medium 199 containing Earle's salts, sodium bicarbonate, horse serum, and antibiotics for 24-48 h. For cytosolic Ca2+ measurements, the cells were incubated for 60 min at 37 °C with 2 µM fura 2-AM in phenol red-free medium 199 containing Hanks' salts, 20 mM sodium bicarbonate, and 20 mM HEPES. Coverslips with cells were washed with phenol red-free physiological buffer and mounted on the stage of an Axiovert 135 microscope (Carl Zeiss, Oberkochen, Germany) attached to an Attofluor digital fluorescence microscopy system (Atto Instruments, Rockville, MD). Cells were examined under a 40× oil immersion objective during exposure to alternating 340- and 380-nm light beams, and the intensity of light emission at 505 nm was measured. [Ca2+]i is expressed as the ratio of 340 nM/380 nM (F(340)/F(380)).

Electrophysiological Recording

Membrane potential (Vm) was measured using the perforated patch-clamp recording technique (16). Before recording, the culture medium was replaced with a solution containing (in mM) 140 NaCl, 4 KCl, 2.6 CaCl2, 1 MgCl2, 10 HEPES, and 5 glucose (pH adjusted to 7.36 using NaOH). Patch-clamp pipettes were fabricated from borosilicate glass (type 7740; World Precision Instruments, Sarasota, FL) using a horizontal micropipette puller (model P-87; Sutter Instrument Co., Novato, CA) and heat polished to a final tip resistance of 2-4 MOmega . The composition of the pipette solutions was (in mM) 70 KCl, 70 K+-aspartate, 1 MgCl2, 10 HEPES (pH adjusted to 7.2 with KOH). Amphotericin B (Sigma) was added from a stock solution to obtain a final concentration of 240 µg/ml. The signals were recorded under the current-clamp mode using an Axopatch 200B patch-clamp amplifier (Axon Instruments, Foster City, CA). A 3 M KCl-agar bridge was placed between the bathing solution and the reference electrode. Records were filtered at 2 kHz using a low pass bessel filter and digitized using the software package AxoScope 1.0 in conjunction with a Digidata 1200A A/D converter (Axon Instruments). All reported membrane potentials were corrected for a liquid junction potential error of 10 mV calculated using the JPCalc program (17). For calcium imaging and electrophysiological experiments, all drugs were either applied directly to the bath or perifused at a rate of 2 ml/min, during which complete solution exchange around the cells occurred within 20-30 s.


RESULTS

In cell column perifusion experiments, continuous stimulation with 100 nM ET-1 induced a rapid and transient increase in prolactin release (Fig. 1A), the amplitude of which was determined by agonist concentration (data not shown). The spike phase was followed by a sustained inhibitory phase, during which prolactin secretion was significantly below that observed in controls (Fig. 1A). Activation of TRH and AII receptors also induced a rapid spike-like pattern of prolactin release; however, unlike the ET-1 response, the spike was followed by a sustained plateau phase, in which prolactin secretion remained elevated above basal levels (Fig. 1B). To determine if the pattern of [Ca2+]i signaling in response to ET-1, TRH, and AII mirrors that of secretion, we monitored changes in [Ca2+]i in single rat lactotrophs using the membrane-permeant Ca2+ indicator dye, fura 2-AM. Endothelin-1 induced a rapid rise in [Ca2+]i, followed by a decrease to below basal levels (Fig. 1C). In contrast, in TRH- and AII-stimulated lactotrophs, the spike phase of the [Ca2+]i response was followed by sustained plateau phase (Fig. 1D).


Fig. 1. Effects of the calcium-mobilizing agonists ET-1, TRH, and AII on cytosolic calcium concentrations ([Ca2+]i) in single cells (C and D) and prolactin (PRL) release from perifused pituitary cells (A and B). Arrows indicate the times of agonist applications. Cells were continuously exposed to agonists from the moment of application to the end of the experiments.

[View Larger Version of this Image (22K GIF file)]


During perifusion of dispersed pituitary cells at a flow rate of 0.6 ml/min with the collection of 1-min fractions, the stimulatory action of ET-1 lasted for 3-5 min (Fig. 1A). This is in contrast to the [Ca2+]i, which was elevated above basal levels for about 1-2 min. To better compare the hormone release response to ET-1 with that of changes in [Ca2+]i, the effects of ET-1 were further examined using a rapid perifusion system, in which the flow rate was adjusted to 1.0 ml/min, and 3-s fractions were collected. The secretory profile was then compared with an averaged [Ca2+]i response from lactotrophs stimulated with 100 nM ET-1. Under these conditions, the hormone release profile mirrored that of the changes in [Ca2+]i (Fig. 2). This further supports the view that the pattern of ET-1-induced changes in [Ca2+]i determines that of prolactin release.


Fig. 2. Comparison of the profiles of [Ca2+]i response and prolactin (PRL) release in pituitary lactotrophs. Calcium tracing represents the computer-derived means of data from 47 lactotrophs. Fractions for prolactin release were collected every 3 s at a flow rate of 1 ml/min.

[View Larger Version of this Image (17K GIF file)]


Another difference in TRH/AII- versus ET-1-stimulated cells was related to the pattern of recovery after the termination of stimuli. The removal of TRH and AII was followed by a return in the [Ca2+]i (Fig. 3A) and secretory responses (data not shown) to basal levels within 1-2 min. In contrast, at least 30 min was required for the recovery of basal [Ca2+]i (Fig. 3B) and prolactin secretion (Fig. 3C) following ET-1 treatment. These data indicate that TRH and AII operate in a manner typical for Ca2+-mobilizing agonists, inducing biphasic effects, which consist of an early spike and sustained plateau responses. Additionally, the stimulatory actions are terminated immediately upon their removal. In contrast, ET-1 exerts bidirectional effects on [Ca2+]i and secretion. This includes an early stimulation followed by a sustained inhibition, the latter being present for a prolonged period upon removal of the agonist.


Fig. 3. Patterns of [Ca2+]i and secretory responses in TRH- and ET-1-stimulated lactotrophs. A and B, effects of addition and removal of TRH and ET-1 on [Ca2+]i in single lactotrophs. In B, the rate of sampling was 60/min during the first 5 min, followed by 3/min. C, stimulation, inhibition, and recovery of secretion in cells perifused at a flow rate of 0.6 ml/min, with a fraction collection of 1 per min. Bar indicates duration of agonist application.

[View Larger Version of this Image (15K GIF file)]


Typical bidirectional effects of ET-1 on [Ca2+]i and secretion were regularly observed in single lactotrophs bathed in Ca2+-containing medium (Figs. 1, 2, 3). In cells bathed in Ca2+-deficient medium, ET-1 induced a monophasic increase in prolactin secretion and [Ca2+]i (Fig. 4, A and B). Thyrotropin-releasing hormone also induced a monophasic increase in [Ca2+]i (Fig. 4C). Readdition of extracellular Ca2+ in TRH- but not ET-1-stimulated cells lead to an immediate increase in [Ca2+]i. Depletion of extracellular Ca2+ consistently reduced [Ca2+]i and prolactin secretion, indicating that Ca2+ entry is coupled to basal [Ca2+]i and prolactin secretion in lactotrophs (Fig. 4, A-C). Thus, it is likely that a common Ca2+ influx pathway controls basal [Ca2+]i and secretion and is facilitated by TRH/AII and inhibited by ET-1.


Fig. 4. Effects of extracellular Ca2+ depletion on basal and agonist-induced Ca2+ responses and prolactin release in perifused pituitary cells. A, comparison of the effects of ET-1 on prolactin release in cells perifused with Ca2+-deficient and Ca2+-containing media. B and C, typical profiles of [Ca2+]i in cells stimulated with 5-min pulses of TRH or ET-1 after removal of extracellular Ca2+ (-Ca2+). At the end of experiments, cells were again perifused with Ca2+-containing medium (+Ca2+).

[View Larger Version of this Image (15K GIF file)]


Previously, it has been suggested that VGCC and SOCC participate in TRH-induced Ca2+ mobilization in lactotrophs (reviewed in Ref. 12). To test for the involvement of VGCC in mediating the inhibitory action of ET-1 on secretion, the interaction between the dihydropyridine Ca2+ channel blockers, nifedipine and nimodipine, and ET-1 was examined. The inhibitory action of ET-1 on prolactin release was decreased, but not completely abolished, in the presence of nifedipine (Fig. 5) and nimodipine (data not shown). As the magnitude of ET-1-induced inhibition of prolactin release was reduced in the presence of dihydropyridines, it suggests that these VGCC blockers and ET-1 act at the same point to inhibit secretion. Nifedipine also reduced basal prolactin release in a manner comparable with that observed in cells depleted of extracellular Ca2+ (Figs. 4 and 5). The effects of nifedipine were concentration dependent (Fig. 5, A versus B). At a higher (100 nM) concentration of nifedipine, ET-1 was still able to inhibit prolactin release, but the level of inhibition was only 10-20% of that observed in control cells (Fig. 5B). In TRH-stimulated cells, the plateau phase of [Ca2+]i response was also reduced by 80-90% in the presence of 100 nM nifedipine. These observations are in accord with the hypothesis that L-type voltage-gated channels are common Ca2+ influx channels involved in the control of [Ca2+]i and secretion in unstimulated and agonist-stimulated lactotrophs. Thus, when the Ca2+ influx through these channels is inhibited by nifedipine, it cannot be further inhibited by ET-1.


Fig. 5. Effects of ET-1 on prolactin (PRL) release in nifedipine-treated perifused pituitary cells. Shaded bar indicates the duration of ET-1 pulse. The dotted line illustrates the difference in the levels of inhibition induced by nifedipine and ET-1. Nifedipine was continuously present from the moment of application.

[View Larger Version of this Image (35K GIF file)]


To further test this hypothesis, membrane potential was measured in single free-running lactotrophs. Under the conditions employed in this study, lactotrophs frequently exhibited spontaneous electrical activity, which was inhibited by addition of nifedipine (not shown). Spontaneous electrical activity was abolished in ET-1 as well as in TRH-stimulated cells (Fig. 6, A and B). However, the pattern of this inhibition differed between the two agonists. Thyrotropin-releasing hormone induced a transient hyperpolarization and cessation of AP firing followed by an increase in the spiking frequency. In contrast, ET-1 induced a long-lasting hyperpolarization with the cessation of AP activity, which returned 15-30 min following its removal. The level of hyperpolarization of lactotrophs by ET-1 was about -80 mV (Fig. 6), which is close to the equilibrium potential for potassium under our experimental conditions. This suggests that inhibition of spontaneous electrical activity is indirect due to activation of a potassium channel, which hyperpolarizes the cells. Depolarization of cells by high potassium (Fig. 7) or the addition of Bay K 8644, an L-type calcium channel agonist (data not shown), increased [Ca2+]i and prolactin secretion, further supporting that inhibition of voltage-gated Ca2+ entry is indirect.


Fig. 6. Changes in membrane potential (Vm) in ET-1 and TRH-stimulated cells. A, ET-1 induced an immediate cessation of action potential firing. Such inhibition was present continuously for at least 30 min following removal of ET-1. B, TRH-induced transient inhibition of firing, which was consistently followed by an increase in the frequency of firing when compared with that before TRH application.

[View Larger Version of this Image (34K GIF file)]



Fig. 7. Depolarization-induced activation of voltage-gated Ca2+ influx in ET-1-stimulated lactotrophs. A, high potassium-induced increase in [Ca2+]i in a lactotroph continuously exposed to 100 nM ET-1. B, effects of high potassium-induced depolarization on prolactin (PRL) secretion in perifused pituitary cells.

[View Larger Version of this Image (15K GIF file)]


During the ET-1-induced inhibition of electrical activity, TRH was unable to induce further hyperpolarization or action potential activity. In contrast, addition of ET-1 to cells continuously stimulated with TRH induced an inhibition of sustained extracellular Ca2+-dependent [Ca2+]i response and prolactin release (Fig. 8, A and B). This experiment demonstrates that activation of ET receptors is required for the inhibitory action on Ca2+ influx. Furthermore, the low amplitude of the spike [Ca2+]i and prolactin responses to ET-1 in TRH-stimulated cells (Fig. 8, A and B) as well as to ionomycin (data not shown) indicates that the ER calcium pool is almost depleted. The amplitudes of TRH-induced [Ca2+]i responses also decreased in cells continuously exposed to 100 nM ET-1 in Ca2+-deficient (Fig. 8D) as well as Ca2+-containing medium (data not shown). The amplitudes of TRH- and ionomycin-induced Ca2+ responses were progressively reduced in cells stimulated with ET-1, indicating that the intracellular Ca2+ pool is depleted within 10-15 min of stimulation (data not shown). Accordingly, application of TRH 20 min after stimulation with ET-1 did not increase prolactin secretion (Fig. 8C).


Fig. 8. Interactions between ET-1 and TRH on [Ca2+]i and prolactin secretion. A and B, inhibitory effect of ET-1 on TRH-induced prolactin release from perifused pituitary cells and [Ca2+]i in three single lactotrophs. C, the lack of effects of TRH on prolactin release in ET-1-stimulated cells. D, reduction in the [Ca2+]i response to TRH following ET-1 treatment. Dotted tracing represents the TRH response in the absence of ET-1.

[View Larger Version of this Image (28K GIF file)]



DISCUSSION

The coupling of Ca2+ influx to a Ca2+ mobilization pathway is commonly observed in non-excitable and excitable cells operated by Ca2+-mobilizing receptors. This coupling is crucial to the regulation of intracellular Ca2+ homeostasis and Ca2+-controlled cellular functions during sustained agonist stimulation (18-21). In non-excitable cells, Ca2+ influx occurs through SOCC in response to agonist-induced and InsP3-mediated depletion of the ER calcium pool (22, 23). In general, Ca2+ influx in these cells is activated independently from the mechanism of depletion of the ER calcium pool (24, 25). In excitable cells, VGCC are involved in sustained agonist-induced Ca2+ entry. In these cells, the pattern of Ca2+ release from intracellular stores (oscillatory versus non-oscillatory) determines the pattern of AP firing and associated voltage-gated Ca2+ entry (1). A family of Ca2+-controlled potassium channels plays a critical role in the synchronization of Ca2+ mobilization with the Ca2+ entry process during agonist stimulation (9). The excitability of these cells, however, does not exclude the operation of SOCC; in several excitable cells, including lactotrophs, capacitative calcium entry has also been identified (26).

Pituitary lactotrophs and GH cell lines express several Ca2+-mobilizing receptors that operate in a manner typical for this class of receptors, i.e. Ca2+ mobilization is coupled to Ca2+ entry. Within them, TRH receptors are the best characterized. They are coupled to a phospholipase C pathway through a Gq/G11 protein (11). Activation of this pathway leads to a non-oscillatory biphasic increase in [Ca2+]i and hormone secretion, the early phase being dependent on Ca2+ mobilization and the sustained phase on Ca2+ entry (27-29) (Figs. 3A and 4C). Both voltage-gated and capacitative Ca2+ entry have been proposed to participate in TRH-induced Ca2+ influx in these cells. The role of VGCC and the pattern of TRH-induced electrical activity is well established (30, 31), whereas the operation of SOCC requires more detailed investigations (12). The other agonist for these cells, AII, signals through AT1B receptors that are also coupled to a phospholipase C pathway (13). Our results indicate that this receptor operates in a manner comparable with that observed during TRH action. Furthermore, lactotrophs express V1b vasopressin and oxytocin receptors, the activation of which are also associated with a biphasic pattern of Ca2+ signaling and prolactin secretion (32, 33).

The ET receptor is an additional member of calcium-mobilizing receptors expressed in lactotrophs as well as in other pituitary cell types (34). The coupling of this receptor to a phospholipase C pathway in pituitary cells (4) provides a transient increase in [Ca2+]i and hormone release (6). In contrast to TRH and AII action, however, the early stimulatory action of ET-1 is substituted with a prolonged inhibition of prolactin release. This was initially observed by Samson et al. (35) and subsequently confirmed by several other groups (6, 36, 37). In accord with the binding data (4), it was suggested that inhibition was mediated by ETA receptors (2-4). In addition to the pituitary cells, inhibition of prolactin release by ET-1 was also observed in human decidual cells (38), which express ETA receptors as well (39). Our data demonstrate that uncoupling of Ca2+ influx from Ca2+ mobilization underlies the bidirectional action of ETs on prolactin release. Thus, ET-1 exhibits two opposite effects on Ca2+ signaling, stimulation via Ca2+ mobilization and inhibition of Ca2+ influx pathways.

The lack of effects of TRH and AII to promote Ca2+ influx in ET-1-stimulated cells and the ability of ET-1 to inhibit Ca2+ entry in TRH/AII-stimulated cells suggest that these receptors control the same Ca2+ influx pathway but show the opposite mode of regulation. Furthermore, the same Ca2+ influx channels control basal [Ca2+]i and prolactin release. Several lines of evidence presented here and earlier indicate that Ca2+ influx through L-type calcium channels rather than SOCC is controlled by these three calcium-mobilizing receptors. (i) Basal prolactin release is inhibited by nifedipine and by depletion of extracellular Ca2+. Spontaneous electrical activity in lactotrophs and GH cells is also inhibited by nifedipine and requires extracellular Ca2+ (40). (ii) TRH-induced electrical activity, Ca2+ influx, and prolactin secretion in these cells are nifedipine-sensitive (27, 29, 30). (iii) ET-1 induces a prolonged inhibition of electrical activity and AP-driven Ca2+ influx through VGCC. The ability of the L-type Ca2+ channels blocker, nifedipine and nimodipine, to diminish the inhibitory action of ET-1 on secretion also suggests that ET-1 acts on VGCC to reduce Ca2+ entry. (iv) Capacitative Ca2+ entry should be activated automatically by depletion of the ER calcium pool in cells expressing SOCC. As shown here, there is a progressive depletion of the ER calcium pool in ET-1- and TRH-stimulated cells, but this action is accompanied with a reverse action on Ca2+ influx by these two receptors, inhibition by ET-1 and stimulation by TRH.

The results also indicate that inhibition of Ca2+ entry through L-type Ca2+ channels is indirect, possibly due to activation of potassium channels, leading to a hyperpolarization and abolition of pacemaker activity. Recently, the role of large-conductance K+ channels in ET-stimulated lactotrophs has been suggested (41). These channels are also activated by TRH and are responsible for a rapid inhibition of electrical activity in lactotrophs (9). Since these channels are controlled by [Ca2+]i, however, the inhibition of AP firing is transient (42) and may explain the early phase in hyperpolarization of these cells. Thus, the sustained inhibition of electrical activity must be controlled by another yet unidentified potassium channel. Future experiments should be directed toward identification of this channel, as well as the mechanism of its activation by ETA receptors, such as direct coupling with G proteins or indirect coupling through intracellular messenger pathways (43, 44).

In the presence of nifedipine, ET-1 is still able to induce a minor inhibition of prolactin release. Also, about 10% of basal extracellular Ca2+-dependent hormone secretion is controlled by Ca2+ influx through nifedipine-insensitive calcium channels. This influx could be mediated by other VGCC subtypes, of which the T-type is the best characterized in these cells (45, 46). It is also possible that the residual, nifedipine-insensitive calcium flux is related to the other family of channels, such as a tetrodotoxin-insensitive sodium channel identified recently in lactotrophs and GH3-immortalized cells (47). Both T-type VGCC and the novel sodium channels are capable of providing the pacemaker activity and are functionally connected to the control of firing of APs. This may provide the explanation for the occurrence of a nifedipine-insensitive Ca2+ influx in unstimulated cells and its inhibition and facilitation by ET-1 and TRH, respectively.

Our results also suggest that both ET-1- and TRH-induced Ca2+ mobilization leads to depletion of the ER Ca2+ pool but that the rate of depletion does not immediately mirror the [Ca2+]i profiles. In cells bathed in Ca2+-deficient medium, application of TRH or ionomycin during the early phase of decreased [Ca2+]i resulted in an additional release of Ca2+. Also, although Ca2+ influx is coupled to Ca2+ mobilization in TRH-stimulated cells, this pathway does not protect the cells from a decrease in the ER calcium pool, as documented by the subsequent application of ET-1 and ionomycin, but is sufficient to keep the steady-state plateau phase in [Ca2+]i response. This is consistent with a model in which the [Ca2+]i in TRH- and ET-1-stimulated lactotrophs represents the balance between Ca2+ mobilization and Ca2+ influx. In ET-1-stimulated cells, Ca2+ mobilization is activated, and AP-driven Ca2+ influx is inhibited, leading to the bidirectional (spike and sustained inhibitory) change in [Ca2+]i and a complete depletion in the intracellular Ca2+ pool. In TRH-stimulated cells, both pathways are activated, leading to the biphasic (spike and plateau) change in [Ca2+]i but accompanied by a progressive decrease in the intracellular Ca2+ pool to a new steady-state level. However, additional experiments are needed to define the cellular Ca2+ homeostasis in lactotrophs.

In summary, our results indicate that the signaling through ETA receptors is essential not only for stimulatory but also for inhibitory actions of ETs on [Ca2+]i and prolactin secretion. The latter function of these receptors is mediated by the uncoupling of Ca2+ mobilization and voltage-gated Ca2+ entry pathways. Such uncoupling leads to a unique physiological situation for a Ca2+-mobilizing agonist: unresponsive cells. The ER calcium pool is depleted due to Ca2+-mobilizing action of the ET-receptor complex, and, without a capacitative refilling, other calcium-mobilizing agonists are unable to initiate Ca2+ mobilization. Prolonged hyperpolarization of lactotrophs also protects these agonists to activate voltage-gated Ca2+ influx in these cells. Finally, basal pacemaker activity and hormone secretion are also inhibited. This makes lactotrophs unresponsive, leading to a sustained hypoprolactinemia. In this regard, a transient stimulatory action of ET-1 probably represents only a first step in the development of a quiescent status of these cells.


FOOTNOTES

*   The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed: NICHD/ERRB/UCS, Bldg. 49, Rm. 6A-36, 49 Convent Dr., Bethesda, MD 20892-4510. Tel.: 301-496-2136; Fax: 301-594-7031; E-mail: stankos{at}helix.nih.gov.
1   The abbreviations used are: ET, endothelin; TRH, thyrotropin-releasing hormone; AII, angiotensin II; ER, endoplasmic reticulum; SOCC, store-operated calcium channel(s); VGCC, voltage-gated calcium channel(s); AP, action potential.

REFERENCES

  1. Stojilkovic, S. S., and Catt, K. J. (1992) Endocr. Rev. 13, 256-280 [Abstract/Free Full Text]
  2. Kanyicska, B., and Freeman, M. E. (1993) Am. J. Physiol. 265, E601-E608 [Abstract/Free Full Text]
  3. Samson, W. K. (1992) Biochem. Biophys. Res. Commun. 187, 590-595 [CrossRef][Medline] [Order article via Infotrieve]
  4. Stojilkovic, S. S., Balla, T., Fukuda, S., Cesnjaj, M., Merelli, F., Krsmanovic, L. Z., and Catt, K. J. (1992) Endocrinology 130, 465-474 [Abstract/Free Full Text]
  5. Cesnjaj, M., Zheng, L., Catt, K. J., and Stojilkovic, S. S. (1995) Mol. Biol. Cell 9, 1037-1047 [Abstract/Free Full Text]
  6. Stojilkovic, S. S., Iida, T., Merelli, F., and Catt, K. J. (1991) Mol. Pharmacol. 39, 762-770 [Abstract]
  7. Samson, W. K., and Skala, K. D. (1992) Endocrinology 130, 2964-2970 [Abstract/Free Full Text]
  8. Kanyicska, B., Livingstone, J. D., and Freeman, M. E. (1995) Endocrinology 136, 990-994 [Abstract]
  9. Ozawa, S., and Sand, O. (1986) Physiol. Rev. 66, 887-952 [Free Full Text]
  10. Stojilkovic, S. S., Izumi, S., and Catt, K. J. (1988) J. Biol. Chem. 263, 13054-13061 [Abstract/Free Full Text]
  11. Gershengorn, M. C., and Osman, R. (1996) Physiol. Rev. 76, 175-191 [Abstract/Free Full Text]
  12. Hinkle, P. M., Nelson, E. J., and Ashworth, R. (1996) Trends Endocrinol. Metab. 7, 370-374 [CrossRef][Medline] [Order article via Infotrieve]
  13. Kakar, S. S., Sellers, J. C., Devor, D. C., Musgrove, L. C., and Neill, J. D. (1992) Biochem. Biophys. Res. Commun. 183, 1090-1096 [CrossRef][Medline] [Order article via Infotrieve]
  14. Tomic, M., Cesnjaj, M., Catt, K. J., and Stojilkovic, S. S. (1994) Endocrinology 135, 1762-1771 [Abstract]
  15. Stojilkovic, S. S, Kukuljan, M., Iida, T., Rojas, E., and Catt, K. J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 4081-4085 [Abstract/Free Full Text]
  16. Kukuljan, M., Stojilkovic, S. S., Rojas, E., and Catt, K. J. (1992) FEBS Lett. 301, 19-22 [CrossRef][Medline] [Order article via Infotrieve]
  17. Barry, P. H. (1994) J. Neurosci. Methods 51, 107-116 [CrossRef][Medline] [Order article via Infotrieve]
  18. Rooney, T. A., Sass, E. J., and Thomas, A. P. (1989) J. Biol. Chem. 264, 17131-17141 [Abstract/Free Full Text]
  19. Loessberg, P. A., Zhao, H., and Muallem, S. (1991) J. Biol. Chem. 266, 1363-1366 [Abstract/Free Full Text]
  20. Zhao, H., Loessberg, P. A., Sachs, G., and Muallem, S. (1990) J. Biol. Chem. 265, 20856-20862 [Abstract/Free Full Text]
  21. Stojilkovic, S. S., Iida, T., Merelli, F., Torsello, A., Krsmanovic, L. Z., and Catt, K. J. (1991) J. Biol. Chem. 266, 10377-10384 [Abstract/Free Full Text]
  22. Putney, J. W., Jr., Bird, G., and St, J. (1993) Endocr. Rev. 14, 610-631 [Abstract/Free Full Text]
  23. Berridge, M. J. (1995) Biochem. J. 312, 1-11
  24. Bird, S. J., Rossier, M. F., Hughes, A. R., Shears, S. B., Armstrong, D. L., and Putney, J. W. (1991) Nature 352, 162-165 [CrossRef][Medline] [Order article via Infotrieve]
  25. Takemura, H., Hughes, A. R., Thastrup, O., and Putney, J. W., Jr. (1989) J. Biol. Chem. 264, 12266-12271 [Abstract/Free Full Text]
  26. Villalobos, C., and Garcia-Sancho, J. (1995) Pflugers Arch. Eur. J. Physiol. 430, 923-935 [CrossRef][Medline] [Order article via Infotrieve]
  27. Albert, P. R., and Tashjian, A. H., Jr. (1984) J. Biol. Chem. 259, 5827-5832 [Abstract/Free Full Text]
  28. Nelson, E. J., and Hinkle, P. M. (1994) Endocrinology 135, 1084-1092 [Abstract]
  29. Winiger, B. P., and Schlegel, W. (1988) Biochem. J. 255, 161-167 [Medline] [Order article via Infotrieve]
  30. Li, P., Thaw, C. N., Sempowski, G. D., Gershengorn, M. C., and Hinkle, P. M. (1992) Mol. Endocrinol. 6, 1393-1402 [Abstract/Free Full Text]
  31. Albert, P. R., and Tashjian, A. H., Jr. (1984) J. Biol. Chem. 259, 15350-15363 [Abstract/Free Full Text]
  32. Samson, W. K., and Schell, D. A. (1995) Adv. Exp. Med. Biol. 395, 355-364 [Medline] [Order article via Infotrieve]
  33. Sugimoto, T., Saito, M., Mochizuki, S., Watanabe, Y., Hashimoto, S., and Kawashima, H. (1994) J. Biol. Chem. 269, 27088-27092 [Abstract/Free Full Text]
  34. Stojilkovic, S. S., and Catt, K. J. (1992) Trends Pharmacol. Sci. 13, 385-391 [CrossRef][Medline] [Order article via Infotrieve]
  35. Samson, W. K., Skala, K. D., Alexander, B. D., and Huang, F. L. (1990) Biochem. Biophys. Res. Commun. 169, 737-743 [CrossRef][Medline] [Order article via Infotrieve]
  36. Kanyicska, B., Burris, T. P., and Freeman, M. E. (1991) Biochem. Biophys. Res. Commun. 174, 338-343 [CrossRef][Medline] [Order article via Infotrieve]
  37. Dymshitz, J., Laudon, M., and Ben-Jonathan, N. (1992) Neuroendocrinology 55, 724-729 [Medline] [Order article via Infotrieve]
  38. Chao, H. -S., Myers, S. E., and Handwerger, S. (1993) Endocrinology 133, 505-510 [Abstract/Free Full Text]
  39. Rutherford, R. A., Wharton, J., McCarthy, A., Gordon, L., Sullivan, M. H., Elder, M. G., and Polak, J. M. (1993) Br. J. Pharmacol. 109, 544-552 [Medline] [Order article via Infotrieve]
  40. Schlegel, W., Winiger, B. P., Mollard, P., Vacher, P., Wuarin, F., Zahnd, G. R., Wollheim, C. B., and Dufy, B. (1987) Nature 329, 719-721 [CrossRef][Medline] [Order article via Infotrieve]
  41. Kanyicska, B., Freeman, M. E., and Dryer, S. E. (1997) Endocrinology 138, 3141-3153 [Abstract/Free Full Text]
  42. Ozawa, S., and Kimura, N. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 6017-6020 [Abstract/Free Full Text]
  43. Hille, B. (1994) Trends Neurosci. 17, 531-536 [CrossRef][Medline] [Order article via Infotrieve]
  44. Wickman, K., and Clapham, D. E. (1995) Physiol. Rev. 75, 865-885 [Abstract/Free Full Text]
  45. Dubinsky, J. M., and Oxford, G. S. (1984) J. Gen. Physiol. 83, 309-339 [Abstract/Free Full Text]
  46. Lewis, D. L., Goodman, M. B., St. John, P. A., and Barker, J. L. (1988) Endocrinology 123, 611-621 [Abstract/Free Full Text]
  47. Sankaranarayanan, S., and Simasko, S. M. (1996) Am. J. Physiol. 271, C1927-C1934 [Abstract/Free Full Text]

Volume 272, Number 45, Issue of November 7, 1997 pp. 28308-28314
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
N. Hatae, N. Aksentijevich, H. W. Zemkova, K. Kretschmannova, M. Tomic, and S. S. Stojilkovic
Cloning and Functional Identification of Novel Endothelin Receptor Type A Isoforms in Pituitary
Mol. Endocrinol., May 1, 2007; 21(5): 1192 - 1204.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
R. Bertram, J. Tabak, N. Toporikova, and M. E. Freeman
Endothelin Action on Pituitary Lactotrophs: One Receptor, Many GTP-Binding Proteins
Sci. Signal., January 24, 2006; 2006(319): pe4 - pe4.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Andric, D. Zivadinovic, A. E. Gonzalez-Iglesias, A. Lachowicz, M. Tomic, and S. S. Stojilkovic
Endothelin-induced, Long Lasting, and Ca2+ Influx-independent Blockade of Intrinsic Secretion in Pituitary Cells by Gz Subunits
J. Biol. Chem., July 22, 2005; 280(29): 26896 - 26903.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Tomic', F. Van Goor, M.-L. He, D. Zivadinovic, and S. S. Stojilkovic
Ca2+-Mobilizing Endothelin-A Receptors Inhibit Voltage-Gated Ca2+ Influx through Gi/o Signaling Pathway in Pituitary Lactotrophs
Mol. Pharmacol., June 1, 2002; 61(6): 1329 - 1339.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Zivadinovic, F. Van Goor, D. Yuan, T.-a. Koshimizu, and S. S. Stojilkovic
Expression of Ca2+-Mobilizing EndothelinA Receptors and Their Role in the Control of Ca2+ Influx and Growth Hormone Secretion in Pituitary Somatotrophs
J. Neurosci., September 15, 1999; 19(18): 7721 - 7731.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. G. Iglesias, G. Diaz-Torga, V. Lux-Lantos, C. Libertun, and D. Becu-Villalobos
Calcium influx and intracellular stores in angiotensin II stimulation of normal and hyperplastic pituitary cells
Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E455 - E463.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. Mair, M. Frick, A. Meraner, H. Schramek, and P. Dietl
Long-term induction of a unique Cl- current by endothelin-1 in an epithelial cell line from rat lung: evidence for regulation of cytoplasmic calcium
J. Physiol., August 15, 1998; 511(1): 55 - 65.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lachowicz, A.
Right arrow Articles by Stojilkovic, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lachowicz, A.
Right arrow Articles by Stojilkovic, S. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement